Balyasny Asset Management LLC Tekla Life Sciences Investors Transaction History
Balyasny Asset Management LLC
- $72.4 Billion
- Q3 2025
A detailed history of Balyasny Asset Management LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Balyasny Asset Management LLC holds 18,340 shares of HQL stock, worth $305,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,340Holding current value
$305,361% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.37MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.59MShares$43.1 Million1.2% of portfolio
-
Morgan Stanley New York, NY871KShares$14.5 Million0.0% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.2 Million0.16% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL423KShares$7.04 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY403KShares$6.72 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...